Virtual Reality Intervention to Reduce Pain in Women Undergoing Elective Oocyte Cryopreservation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorHadassah Medical Organization

About this trial

This randomized controlled study evaluates whether exposure to relaxing virtual reality (VR) scenery prior to oocyte retrieval can reduce pain in women undergoing elective oocyte cryopreservation.

Many women experience discomfort before and after oocyte retrieval. Virtual reality has been shown to reduce pain in various medical settings by providing distraction and relaxation.

In this study, participants are randomly assigned to receive either routine care alone or routine care combined with a VR-based relaxation intervention while waiting for the procedure.

Pain is assessed using validated questionnaires and standardized scales before and after oocyte retrieval.

The results of this study may help determine whether VR can serve as a simple, safe, and non-pharmacological method to improve patient comfort during elective egg freezing.

Eligibility criteria

Qualifiers

Women undergoing elective oocyte retrieval for fertility preservation.

Age 18-45 years.

Ability to provide informed consent.

Disqualifiers

Use of pain relief, anti-anxiety, or antidepressant medications prior to the intervention.

History of seizures

Sensitivity to flashing light or motion

Migraine headaches

Trial design

Treatments tested in this trial

  • Virtual reality relaxation intervention
  • Standard Care Control

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators